Royal Bank of Canada’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $754K | Buy |
599,231
+574,491
| +2,322% | +$723K | ﹤0.01% | 3829 |
|
|
2025
Q1 | $23K | Sell |
24,740
-12,614
| -34% | -$11.7K | ﹤0.01% | 5481 |
|
|
2024
Q4 | $59K | Sell |
37,354
-1,331
| -3% | -$2.1K | ﹤0.01% | 5121 |
|
|
2024
Q3 | $76K | Sell |
38,685
-4,124
| -10% | -$8.1K | ﹤0.01% | 5047 |
|
|
2024
Q2 | $71K | Buy |
42,809
+4,052
| +10% | +$6.72K | ﹤0.01% | 5089 |
|
|
2024
Q1 | $199K | Sell |
38,757
-243,180
| -86% | -$1.25M | ﹤0.01% | 4266 |
|
|
2023
Q4 | $1.62M | Buy |
281,937
+249,997
| +783% | +$1.43M | ﹤0.01% | 2795 |
|
|
2023
Q3 | $153K | Buy |
31,940
+23,834
| +294% | +$114K | ﹤0.01% | 4561 |
|
|
2023
Q2 | $34K | Buy |
8,106
+2,785
| +52% | +$11.7K | ﹤0.01% | 5496 |
|
|
2023
Q1 | $29K | Sell |
5,321
-3,187
| -37% | -$17.4K | ﹤0.01% | 5495 |
|
|
2022
Q4 | $54K | Buy |
8,508
+5,655
| +198% | +$35.9K | ﹤0.01% | 5362 |
|
|
2022
Q3 | $30K | Buy |
2,853
+379
| +15% | +$3.99K | ﹤0.01% | 5484 |
|
|
2022
Q2 | $14K | Sell |
2,474
-2,250
| -48% | -$12.7K | ﹤0.01% | 5774 |
|
|
2022
Q1 | $44K | Buy |
4,724
+966
| +26% | +$9K | ﹤0.01% | 5692 |
|
|
2021
Q4 | $58K | Buy |
3,758
+1,000
| +36% | +$15.4K | ﹤0.01% | 5754 |
|
|
2021
Q3 | $66K | Buy |
+2,758
| New | +$66K | ﹤0.01% | 5476 |
|